Search

Your search keyword '"Kalinova M"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Kalinova M" Remove constraint Author: "Kalinova M"
86 results on '"Kalinova M"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. VARIANT ALK-FUSION POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A POPULATION-BASED COHORT OF THE NHL-BFM STUDY GROUP

4. Das nationale Projekt Elbe II in den Jahren 1996–1997

5. RT-PCR-Based Detection of TEL/AML1 Fusion Transcript in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia — a Czech Childhood Leukemia Working Group Experience

17. R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS

22. ALK‐POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WITH VARIANT ALK‐FUSION PARTNER: A POPULATION‐BASED ANALYSES OF THE NHL‐BFM STUDY GROUP.

23. Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study

28. Real-time quantitative PCR detection of WT1 gene expression in children with AML.

33. Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study

34. Changes in memory and cognition during the SARS-CoV-2 human challenge study.

35. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults.

36. Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

37. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.

38. Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

39. Freud in Bulgaria: Psychoanalysis, Literature, Translation: An Experience with the Singular.

40. Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.

41. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.

42. Lack of association between HLA and asymptomatic SARS-CoV-2 infection.

43. Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.

44. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

45. Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.

46. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.

47. Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance.

48. Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.

49. Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

50. The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma.

Catalog

Books, media, physical & digital resources